Hims Shareholder Files Derivative Complaint Over Compounded Semaglutide
SAN FRANCISCO — A shareholder of Hims & Hers Health Inc. on July 17 filed a stockholder derivative action in a California federal court on behalf of the company, accusing the...To view the full article, register now.
Already a subscriber? Click here to view full article